NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
3.300
0.00 (0.00%)
Nov 21, 2024, 11:30 AM EST - Market open
NEXGEL Employees
NEXGEL had 19 employees as of December 31, 2023. The number of employees increased by 7 or 58.33% compared to the previous year.
Employees
19
Change (1Y)
7
Growth (1Y)
58.33%
Revenue / Employee
$354,158
Profits / Employee
-$185,737
Market Cap
24.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Bionano Genomics | 344 |
Neuronetics | 203 |
Bolt Biotherapeutics | 100 |
Enlivex Therapeutics | 71 |
Chemomab Therapeutics | 20 |
NeurAxis | 19 |
NeuroSense Therapeutics | 18 |
NeuroOne Medical Technologies | 16 |
NXGL News
- 7 days ago - NEXGEL, Inc. (NXGL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially - GlobeNewsWire
- 9 days ago - NEXGEL Announces $2,000,000 Registered Direct Offering - GlobeNewsWire
- 5 weeks ago - NEXGEL to Participate in Upcoming October Investor Conferences - GlobeNewsWire
- 6 weeks ago - NEXGEL Appoints Kip Crecca to its Scientific Advisory Board - GlobeNewsWire
- 3 months ago - NEXGEL, Inc. (NXGL) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million - GlobeNewsWire
- 3 months ago - NEXGEL to Report Second Quarter 2024 Financial Results on August 14th - GlobeNewsWire